Therefore the detection of CEA or TIMP1 as cancer biomarkers is crucial for cancer diagnosis, or more specifically, for the monitoring of patients who suffer from cancer which produce CEA after and before getting chemotherapy, surgery, radiation, or combination of all [36,37]. This evidence concerns the gene CEACAM5 and cancer.